Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Ancient Mushroom, Modern Medicine: Paul Stamets Says Agarikon Mycelium May Be Key to Fighting Viral Pandemics

    Mar 12, 2026, 01:34 AM by User Not Found
    Bio-IT World | Paul Stamets has spent more than four decades in the forests of the Pacific Northwest, carefully prying tissue samples from the undersides of some of the world’s rarest mushrooms. On the stage of February’s Integrative Health Symposium, that lifetime of fieldwork converged with randomized clinical trials and Department of Defense contracts—a collision of ancient ethnobotany and 21st-century immunology that left the audience energized.
    Full story
  • Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies

    Mar 11, 2026, 09:50 AM by
    Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the addition of optical genome mapping (OGM) and long‑read sequencing (LRS) as supplemental technologies. These advanced technologies — along with RNA sequencing — enable the company’s WGS test to go beyond standard sequencing approaches, providing a more precise view of a patient’s genome and delivering more answers to help guide patient care and outcomes.
    Full story
  • University of Colorado Grants License to Cirena for RNA-Synthesis Technology

    Mar 11, 2026, 09:50 AM by
    Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology.
    Full story
  • Russia to Expand National Genetics Database to Ensure Treatment for Various Ethnic Groups

    Mar 11, 2026, 01:01 AM by User Not Found
    Bio-IT World | Russia is significantly expanding the existing national database of genetic variant frequencies of the domestic population in a move to improve treatment of some socially important diseases and reduce the mortality rate from them.
    Full story
  • Abselion Establishes US Subsidiary in Cambridge, MA

    Mar 10, 2026, 08:46 AM by
    Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform
    Full story
  • Neuland to open commercial peptide facility as part of planned phased expansion

    Mar 10, 2026, 08:46 AM by
    Full story
  • How HPC Systems Are Making Things Easier

    Mar 10, 2026, 01:01 AM by User Not Found
    Bio-IT World | In the newest episode of Trends from the Trenches, guest host Jessica StLouis, senior scientific consultant at BioTeam, speaks with Jarett DeAngelis, director of scientific computing, and Shane Corder, senior HPC engineer, both at the Moffitt Cancer Center. Their conversation centers on how Moffitt is redesigning HPC infrastructure to reduce friction in research collaboration, streamline data sharing, and expand access to advanced computational resources.
    Full story
  • Third Annual Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston May 19

    Mar 6, 2026, 08:14 AM by
    Cambridge Healthtech Institute today announced the agenda for the third annual Bio-IT World Venture, Innovation & Partnering Conference, an exclusive gathering of more than 200 senior-level investors, corporate executives, entrepreneurs and startups, with a focus on connecting capital, technology, and science to accelerate drug discovery.
    Full story
  • More Than Half of GLP-1 Users Reported Seeking Follow-Up Care for Side Effects, Phenomix Sciences Report Finds

    Mar 6, 2026, 08:14 AM by
    In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care. Real-world response varies: Many GLP-1 users reported variability in outcomes, including weight-loss plateaus, limited response, or weight gain. Care and costs often extend beyond the prescription: More than half of users required medical care to manage side effects, with some reporting significant out-of-pocket costs. One-size-fits-all falls short: The findings highlight that obesity treatment outcomes differ widely, reinforcing the need for more individualized approaches to care.
    Full story
  • Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

    Mar 6, 2026, 08:14 AM by
    Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies.
    Full story
  • Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

    Mar 6, 2026, 08:14 AM by
    Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.
    Full story
  • Infant Microbiome Atlas Makes Case for Region-Specific Probiotics

    Mar 5, 2026, 01:00 AM by User Not Found
    Bio-IT World | When it comes to the microbiome, “our bodies are beautifully designed for a world that no longer exists." The bugs inhabiting our gut are a good match for high-fiber, plant-based dietary habits that have been largely replaced by processed foods that are killing off health-promoting bacteria and allowing more harmful varieties to dominate.
    Full story
  • Ardena Appoints Paul Edwards as Chief People Officer

    Mar 4, 2026, 09:35 AM by
    Full story
  • Camgenium Expands NHS Access to Advanced, Risk-Adjusted Clinical Audit Analytics

    Mar 4, 2026, 09:35 AM by
    Full story
  • Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

    Mar 4, 2026, 09:35 AM by
    • Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley
    Full story
  • MIT Develops Biodegradable “Smart Pill” to Track Medication Adherence

    Mar 4, 2026, 01:00 AM by User Not Found
    Bio-IT World | Medication nonadherence has long been one of healthcare’s most stubborn problems. Roughly half of patients with chronic conditions do not take their medications as prescribed, according to the World Health Organization. This problem undermines treatment, fuels drug resistance, and costs the U.S. healthcare system hundreds of billions of dollars each year. However, engineers at MIT might be able to offer a new way forward.
    Full story
  • Lee Hood’s Persistent Plan to Reinvent Medicine From the Ground Up

    Mar 3, 2026, 01:01 AM by User Not Found
    Bio-IT World | When Leroy Hood stepped up to the podium at last week's Integrative Healthcare Symposium to accept the Visionary Award, he told the audience he had done 200 push-ups before coming downstairs that morning. He is 87 years old. It was a fitting opening for a talk that was equal parts intellectual autobiography, scientific tour de force, and provocation—a challenge to an entire healthcare system that Hood believes is looking at the problem of human health almost entirely backwards.
    Full story
  • Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

    Mar 2, 2026, 11:29 AM by
    Following Proscia’s Global Best in KLAS win in Europe, Concentriq is now the highest-rated digital pathology platform across multiple regions
    Full story
  • START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit

    Mar 2, 2026, 11:26 AM by
    Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions.
    Full story
  • Symbiosis Appoints Joanne Anderson as Chief Commercial Officer

    Mar 2, 2026, 08:24 AM by
    Full story
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy